PBAC to review FP 50 decision Controls placed on GPs initiating PBS prescriptions of the commonly used paediatric asthma medicine will be revisited at the next intracycle meeting.
FP 50 restriction sparks prescribing authority debate GPs have questioned why some medications can only be prescribed by certain specialties, calling differential access to the PBS ‘utterly illogical’.
RACGP joins fight against asthma med change The college has written to the PBAC Chair about potential grave consequences for families due to new restrictions on fluticasone propionate 50 mcg.
Changes made to COVID Vaccine Claims Scheme The Department of Health and Aged Care has removed and added certain conditions that can be claimed in relation to COVID vaccine adverse reactions.
New year brings cheaper medicines The maximum cost of subsidised prescriptions has been cut for the first time since the PBS was introduced 75 years ago.
Reflux treatment among medicines added to PBS Medication for a host of conditions will be newly subsidised from October, potentially generating $130 million in out-of-pocket savings.
‘Nonsensical’ to stop GPs approving access to glucose monitors The decision to block GPs from certifying patient access to the devices ‘needs to be reviewed and rectified,’ the RACGP president says.
Paxlovid goes on PBS as GPs urged to avoid private prescribing This is the first week the COVID-19 treatment has been available on the PBS, meaning two oral antiviral medications can now be prescribed by general practice.
COVID antiviral order doubled ahead of PBS listing Paxlovid will be available on the Pharmaceutical Benefits Scheme from May, with ‘really positive responses’ reported so far.
Thousands expected to benefit from new PBS listings Medications for asthma, HIV, and Crohn’s disease have been added, while some heart, cholesterol and blood pressure drugs are now cheaper.